TFX · Teleflex Incorporated
$130.99
-0.77% last session
End-of-day data · close of 2026-09-11
Market cap
$6B
Enterprise value
$8B
Trailing P/E
—
Forward P/E
12.1
Dividend yield
1.0%
Beta
0.81
Avg volume
1M
Employees
16K
Daily Change %
-0.77%
5 Days Change
-1.91%
10 Days Change
-4.46%
30 Days Change
1.88%
60 Days Change
0.24%
Month to Day Change
-3.39%
Year to Day Change
12.10%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — TFX
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-08-25
Latest call per bank · past 12 months
UBS
Neutral$158
+19.7% vs priceRBC Capital
Outperform$155
+17.4% vs priceWells Fargo
Equal-Weight$138
+4.5% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-25 | Needham | Maintains | Buy | $159 → $170 |
| 2026-08-11 | UBS | Maintains | Neutral | $145 → $158 |
| 2026-08-10 | Truist Securities | Maintains | Hold | $143 → $150 |
| 2026-08-07 | Piper Sandler | Reiterates | Overweight | $160 → $169 |
| 2026-07-31 | Needham | Maintains | Buy | $147 → $159 |
| 2026-07-28 | UBS | Initiates | Neutral | $0.00 → $145 |
| 2026-07-15 | Mizuho | Maintains | Neutral | $140 → $145 |
| 2026-07-09 | BMO Capital | Initiates | Outperform | $0.00 → $159 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-09-11
- RSI (14): RSI is 39 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 3.3% below the 50-day MA ($135.42).
- Price vs 200-day MA: Trading 6.4% above the 200-day MA ($123.10).
- MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- MACD (12,26,9): MACD histogram is negative (-1.05) — short-term momentum is fading.
- 52-week range: Price sits between the 52-week low ($99.54) and high ($142.05).
TFX Price Chart
Loading chart for TFX…
Fundamentals
About Teleflex Incorporated
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters. In addition, the company offers surgical products, including metal and polymer ligating clips using manual and automatic applier system, fascial closure surgical systems used in laparoscopic surgical procedures, percutaneous surgical systems, powered bariatric staplers, and other surgical instruments under the Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, and Titan SGS brands. It serves hospitals, healthcare providers, and medical device manufacturers. The company also sells its products online. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
More in Medical Instruments & Supplies
ISRG
Intuitive Surgical, Inc.
$129B -37.6% YTD
BDX
Becton, Dickinson and Company
$48B 20.1% YTD
MDLN
Medline Inc.
$44B -18.9% YTD
ALC
Alcon Inc.
$32B -12.8% YTD
RMD
ResMed Inc.
$32B -7.9% YTD
WST
West Pharmaceutical Services, I
$24B 22.8% YTD
SOLV
Solventum Corporation
$15B 13.6% YTD
BAX
Baxter International Inc.
$13B 27.8% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.